Mizuho Upgrades Eagle Pharmaceuticals (EGRX) to Buy Following Unexpected J-code Win; Sees 60% Chance of a Takeout
Tweet Send to a Friend
Mizuho Securities upgraded Eagle Pharmaceuticals (NASDAQ: EGRX) from Neutral to Buy with a price target of $78.00 (from $62.00) following ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
